JP2019505596A5 - - Google Patents

Download PDF

Info

Publication number
JP2019505596A5
JP2019505596A5 JP2018563379A JP2018563379A JP2019505596A5 JP 2019505596 A5 JP2019505596 A5 JP 2019505596A5 JP 2018563379 A JP2018563379 A JP 2018563379A JP 2018563379 A JP2018563379 A JP 2018563379A JP 2019505596 A5 JP2019505596 A5 JP 2019505596A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
adpr
disease
adenovirus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018563379A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019505596A (ja
JP6946353B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/018253 external-priority patent/WO2017143113A1/en
Publication of JP2019505596A publication Critical patent/JP2019505596A/ja
Publication of JP2019505596A5 publication Critical patent/JP2019505596A5/ja
Priority to JP2021149881A priority Critical patent/JP7222042B2/ja
Application granted granted Critical
Publication of JP6946353B2 publication Critical patent/JP6946353B2/ja
Priority to JP2023014497A priority patent/JP7600282B2/ja
Priority to JP2024210859A priority patent/JP2025032189A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018563379A 2016-02-18 2017-02-17 5′−アデノシン二リン酸リボース(adpr)の使用方法 Active JP6946353B2 (ja)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP2021149881A JP7222042B2 (ja) 2016-02-18 2021-09-15 5′-アデノシン二リン酸リボース(adpr)の使用方法
JP2023014497A JP7600282B2 (ja) 2016-02-18 2023-02-02 5′-アデノシン二リン酸リボース(adpr)の使用方法
JP2024210859A JP2025032189A (ja) 2016-02-18 2024-12-04 5′-アデノシン二リン酸リボース(adpr)の使用方法

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201662296665P 2016-02-18 2016-02-18
US62/296,665 2016-02-18
US201662428721P 2016-12-01 2016-12-01
US62/428,721 2016-12-01
PCT/US2017/018253 WO2017143113A1 (en) 2016-02-18 2017-02-17 Methods for the use of 5'-adenosine diphosphate ribose (adpr)

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021149881A Division JP7222042B2 (ja) 2016-02-18 2021-09-15 5′-アデノシン二リン酸リボース(adpr)の使用方法

Publications (3)

Publication Number Publication Date
JP2019505596A JP2019505596A (ja) 2019-02-28
JP2019505596A5 true JP2019505596A5 (cg-RX-API-DMAC7.html) 2020-04-02
JP6946353B2 JP6946353B2 (ja) 2021-10-06

Family

ID=58191671

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2018563379A Active JP6946353B2 (ja) 2016-02-18 2017-02-17 5′−アデノシン二リン酸リボース(adpr)の使用方法
JP2021149881A Active JP7222042B2 (ja) 2016-02-18 2021-09-15 5′-アデノシン二リン酸リボース(adpr)の使用方法
JP2023014497A Active JP7600282B2 (ja) 2016-02-18 2023-02-02 5′-アデノシン二リン酸リボース(adpr)の使用方法
JP2024210859A Pending JP2025032189A (ja) 2016-02-18 2024-12-04 5′-アデノシン二リン酸リボース(adpr)の使用方法

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2021149881A Active JP7222042B2 (ja) 2016-02-18 2021-09-15 5′-アデノシン二リン酸リボース(adpr)の使用方法
JP2023014497A Active JP7600282B2 (ja) 2016-02-18 2023-02-02 5′-アデノシン二リン酸リボース(adpr)の使用方法
JP2024210859A Pending JP2025032189A (ja) 2016-02-18 2024-12-04 5′-アデノシン二リン酸リボース(adpr)の使用方法

Country Status (16)

Country Link
US (3) US11110112B2 (cg-RX-API-DMAC7.html)
EP (2) EP3978003A1 (cg-RX-API-DMAC7.html)
JP (4) JP6946353B2 (cg-RX-API-DMAC7.html)
KR (2) KR102622656B1 (cg-RX-API-DMAC7.html)
CN (2) CN117482102A (cg-RX-API-DMAC7.html)
AU (2) AU2017219878B2 (cg-RX-API-DMAC7.html)
BR (1) BR112018016398A2 (cg-RX-API-DMAC7.html)
DK (1) DK3416654T3 (cg-RX-API-DMAC7.html)
ES (1) ES2900524T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20211942T1 (cg-RX-API-DMAC7.html)
HU (1) HUE057052T2 (cg-RX-API-DMAC7.html)
IL (2) IL291574B2 (cg-RX-API-DMAC7.html)
LT (1) LT3416654T (cg-RX-API-DMAC7.html)
PL (1) PL3416654T3 (cg-RX-API-DMAC7.html)
PT (1) PT3416654T (cg-RX-API-DMAC7.html)
WO (1) WO2017143113A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE057052T2 (hu) 2016-02-18 2022-04-28 Invirsa Inc 5'-adenozin-difoszfát-ribóz (ADPR) gyógyászati alkalmazása
WO2019191026A2 (en) * 2018-03-27 2019-10-03 Invirsa, Inc. Methods for the use of 5'-adenosine diphosphate ribose (adpr)
KR102789553B1 (ko) * 2021-09-07 2025-04-03 주식회사 펄스인마이어스 방사선 및/또는 항암 치료 보조 요법으로 아데노신 디포스페이트 리보오스의 활용
WO2024181817A1 (ko) * 2023-03-02 2024-09-06 주식회사 펄스인마이어스 암의 예방 또는 치료를 위한 adp-리보오스 결합 펩티드 및 adp-리보오스의 병용 요법
WO2026073064A1 (en) * 2024-09-30 2026-04-02 Invirsa, Inc. 5'-adenosine diphosphate ribose (adpr) for use in improving visual acuity

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0618214A1 (en) 1993-04-01 1994-10-05 Merrell Dow Pharmaceuticals Inc. Unsaturated phosphonate derivatives of purines and pyrimidines
JPH07247210A (ja) 1994-03-09 1995-09-26 Sunstar Inc 口腔用組成物
CA2302687A1 (en) * 1997-09-11 1999-03-18 Oxigene, Inc. Uses of nicotinamide adenine dinucleotide and its analogs for treatment of malignant and infectious diseases
KR20010114214A (ko) 1999-02-26 2001-12-31 인스파이어 파마슈티컬스 인코퍼레이티드 우리딘, 아데닌 및 시티딘 디포스페이트 및 그의 유사체에의한 점막수화 촉진방법
CN1370238A (zh) 1999-06-16 2002-09-18 艾科斯有限公司 人聚(adp-核酸)聚合酶2的物质和方法
US6528042B1 (en) 1999-10-08 2003-03-04 Galileo Laboratories, Inc. Compositions of flavonoids for use as cytoprotectants and methods of making and using them
US7115585B2 (en) 2000-08-21 2006-10-03 Inspire Pharmaceuticals, Inc. Compositions for treating epithelial and retinal tissue diseases
US20050009777A1 (en) 2001-07-25 2005-01-13 Mack Stephen Robert Non-natural carbon-linked nucleotides and dinucleotides
US20030236217A1 (en) 2002-05-21 2003-12-25 Shalwitz Robert A. Treatment of mucositis
US20070212395A1 (en) 2006-03-08 2007-09-13 Allergan, Inc. Ocular therapy using sirtuin-activating agents
US20050276762A1 (en) * 2004-06-15 2005-12-15 Tapas Das Topical compositions containing 5'-adenosine-diphosphate ribose
CA2609549A1 (en) 2005-05-25 2006-11-30 Sirtris Pharmaceuticals, Inc. Treatment of eye disorders with sirtuin modulators
JP5221368B2 (ja) 2005-11-14 2013-06-26 サントル ナシオナル ドゥ ラ ルシェルシェサイアンティフィク(セエヌエールエス) Parp活性のインヒビター及びその使用
WO2008154129A1 (en) 2007-06-08 2008-12-18 Bausch & Lomb Incorporated Pharmaceutical compositions and method for treating, reducing, ameliorating, alleviating, or preventing dry eye
US20110217262A1 (en) 2010-03-05 2011-09-08 Kornfield Julia A Treatment of Ocular Surface Disorders by Increasing Conjunctival Vascular Permeability
WO2011141909A2 (en) 2010-05-10 2011-11-17 Radikal Therapeutics Inc. Lipoic acid and nitroxide derivatives and uses thereof
MX360666B (es) 2011-05-12 2018-11-13 Foresight Biotherapeutics Inc Composiciones de yodopovidona estables con antiinflamatorios esteroides y no esteroides.
US20160287622A1 (en) 2013-11-18 2016-10-06 Massachusetts Institute Of Technology Compositions and methods for treating immune and viral disorders and modulating protein-rna interaction
HUE057052T2 (hu) 2016-02-18 2022-04-28 Invirsa Inc 5'-adenozin-difoszfát-ribóz (ADPR) gyógyászati alkalmazása
WO2019191026A2 (en) 2018-03-27 2019-10-03 Invirsa, Inc. Methods for the use of 5'-adenosine diphosphate ribose (adpr)

Similar Documents

Publication Publication Date Title
ES2675588T3 (es) Dendrímero como aminoamidas que posee actividad de bloqueador de canal de sodio para el tratamiento del ojo seco y otras enfermedades mucosas
JP7600282B2 (ja) 5′-アデノシン二リン酸リボース(adpr)の使用方法
RU2015129062A (ru) Соединения 3, 5-диамино-6-хлор-n-(n-(4-фенилбутил)карбамимидоил)пиразин-2-карбоксамида
JP2021519315A5 (cg-RX-API-DMAC7.html)
JP2023071933A5 (cg-RX-API-DMAC7.html)
ES2825700T3 (es) Derivados de pirimidina sustituidos útiles en el tratamiento de enfermedades autoinmunitarias
US20250092077A1 (en) Dithiolsaccharide mucolytic agents and uses thereof
RU2015129076A (ru) Арилалкил- и арилоксиалкил-замещенные соединения, блокирующие эпителиальный натриевый канал
US20110166149A1 (en) Pteridine derivatives for treating respiratory disease
JP2009500354A (ja) 肺疾患を治療するためのp2y6受容体アゴニスト
US20240335410A1 (en) Compositions and methods for stimulating ventilatory and/or respiratory drive
JP4232866B2 (ja) 細胞障害抑制剤
JP6871919B2 (ja) 薬物送達及びイメージング化学コンジュゲート、製剤及びその使用方法
CA3014071C (en) Methods for the use of 5'-adenosine diphosphate ribose (adpr)
JP2013001677A (ja) 抗コリン作動薬を含む再発性多発軟骨炎を含む気管気管支軟化症の治療剤
WO2005041858A2 (ja) ムチン産生抑制剤